Linked from

The 12 pages that link to Antidepressant discontinuation syndrome, each with the reason it gives.

• Selective serotonin reuptake inhibitorRelated: Gradual tapering can reduce discontinuation symptoms, whose likelihood varies among SSRIs.

• AntidepressantRelated: Changes in drug exposure can produce symptoms distinct from depression returning.

• Serotonin-norepinephrine reuptake inhibitorRelated: Shorter-acting SNRIs, especially venlafaxine, can cause prominent symptoms when stopped suddenly.

• FluoxetineCompared with: Fluoxetine’s long half-life generally makes discontinuation symptoms less common than with shorter-acting SSRIs.

• VenlafaxineRelated: Venlafaxine's short half-life makes discontinuation symptoms particularly likely after missed doses or rapid tapering.

• Benzodiazepine withdrawal syndromeCompared with: Both syndromes follow medication reduction, but their symptom patterns and risks differ.

• Psychiatric medicationBroader topic: Gradual dose changes may reduce discontinuation symptoms when treatment ends or changes.

• PsychopharmacologyBroader topic: It makes tapering and clear counseling relevant to antidepressant treatment.

• Pregnancy and antidepressantsRelated: Stopping medication suddenly can cause symptoms and complicate decisions about treatment during pregnancy.

• ParoxetineRelated: Paroxetine’s short half-life makes discontinuation symptoms especially relevant.

• EscitalopramRelated: Stopping escitalopram suddenly can produce these symptoms.

• FluvoxamineRelated: Stopping fluvoxamine suddenly may cause withdrawal-like symptoms.